Novel anticancer agents: Grant awarded to Yvonne Kreith

07.11.2018

Uni:doc's Fellow Yvonne Kreith now received funding from the Hochschuljubiläumsstiftung of the City of Vienna for her studies on novel cancer drugs. The doctoral candidate from the Institute of Inorganic Chemistry will use these funds to spend three months at the UCL School of Pharmacy in London in spring 2019. The aim is to develop substances with higher selectivity for tumour tissue.

Yvonne Kreith received a grant from the Hochschuljubiläumsstiftung of the City of Vienna (Copyright: private).